BNP Paribas Financial Markets
XERS icon

BNP Paribas Financial Markets’s Xeris Biopharma Holdings XERS Stock Holding History

BNP Paribas Financial Markets’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41M Buy
430,488
+167,701
+64% +$1.07M ﹤0.01% 2412
2026
Q1 		$1.52M Buy
262,787
+4,419
+2% +$29.3K ﹤0.01% 2841
2025
Q4 		$2.03M Sell
258,368
-323,351
-56% -$2.54M ﹤0.01% 2606
2025
Q3 		$4.74M Buy
581,719
+565,409
+3,467% +$3.76M ﹤0.01% 2019
2025
Q2 		$76.2K Sell
16,310
-328,578
-95% -$1.51M ﹤0.01% 4102
2025
Q1 		$1.89M Buy
344,888
+244,876
+245% +$988K ﹤0.01% 2398
2024
Q4 		$339K Buy
+100,012
New +$322K ﹤0.01% 3547
2021
Q4 		– Sell
-1,118
Closed -$2.74K – 4281
2021
Q3 		$2.74K Sell
1,118
-700
-39% -$2.03K ﹤0.01% 3763
2021
Q2 		$7.4K Sell
1,818
-4,182
-70% -$16K ﹤0.01% 3774
2021
Q1 		$27.1K Sell
6,000
-3,150
-34% -$17K ﹤0.01% 3715
2020
Q4 		$45K Sell
9,150
-1,935
-17% -$9.68K ﹤0.01% 3605
2020
Q3 		$65.7K Buy
11,085
+8,181
+282% +$32.7K ﹤0.01% 3335
2020
Q2 		$7.72K Sell
2,904
-6,330
-69% -$22K ﹤0.01% 3820
2020
Q1 		$18K Buy
9,234
+6,162
+201% +$26.5K ﹤0.01% 3928
2019
Q4 		$21.7K Sell
3,072
-483
-14% -$3.99K ﹤0.01% 3978
2019
Q3 		$34.9K Buy
3,555
+1,242
+54% +$14K ﹤0.01% 3677
2019
Q2 		$26.5K Sell
2,313
-1,974
-46% -$20.7K ﹤0.01% 3795
2019
Q1 		$43K Buy
+4,287
New +$54.9K ﹤0.01% 3589

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BNP Paribas Financial Markets's XERS Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Xeris Biopharma Holdings (XERS) stake by 64% in Q2 2026, buying an estimated $1.07M and bringing the position to 430,488 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2412.

BNP Paribas Financial Markets first reported a position in XERS in Q1 2019 and has held it in 18 quarters since. The position peaked at $4.74M in Q3 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • BNP Paribas Financial Markets held 430,488 shares of Xeris Biopharma Holdings worth $3.41M as of Q2 2026.
  • BNP Paribas Financial Markets bought 167,701 Xeris Biopharma Holdings shares in Q2 2026, an estimated $1.07M.
  • Xeris Biopharma Holdings made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2412 holding.
  • BNP Paribas Financial Markets first reported a position in Xeris Biopharma Holdings in Q1 2019 and has held it in 18 quarters since.
  • BNP Paribas Financial Markets's Xeris Biopharma Holdings position peaked at $4.74M in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.